NEWS Safeguarding Adults and identifying risk
Northern Ireland Health Trusts could save £400,000 with Zeroderma emollients
The Zeroderma emollient range now offers more choice with four creams, one ointment, one gel and two bath additives - providing complete emollient therapy for moisturising, washing and bathing.
Pharmacists, their teams and allied healthcare professionals have a key role in the identification of risks of harm to assist in improve safeguarding arrangements for adults who are at risk of harm from abuse, exploitation or neglect for the purpose of reducing the prevalence of harm.
Very often Pharmacists and GPs will be the first point of contact for adults and their families where an individual’s needs are changing and they require further support.
They are central in the identification of risks of harm and ensuring appropriate referral to the HSC Trust for a further assessment of needs and/or risks.
The Department of Health recently launched guidance on their Adult Safeguarding Policy which encompasses an impact for community pharmacy in Northern Ireland.
Health services have a duty to safeguard all patients but provide additional measures for patients who are less able to protect themselves from harm or abuse.
‘Safeguarding adults’ covers a spectrum of activity from prevention through to multi agency responses where harm and abuse occurs.
Multi agency procedures apply where there is concern of neglect, harm or abuse to a patient defined under No Secrets guidance as ‘vulnerable’.
Safeguarding adults is an integral part of patient care. Duties to safeguard patients are required by professional regulators, service regulators and supported in law.
It provides a framework to help ensure supports are available to adults at risk, and that effective protective interventions are provided. It places significant emphasis on prevention and early intervention. It also seeks to ensure that access to justice is available to adults that have been harmed.
The policy is for all organisations working with, or providing services to, adults across the statutory, voluntary, community, independent and faith sectors. It sets clear and proportionate
safeguarding expectations across the range of organisations.
A key objective is to reduce the incidence of harm from abuse, exploitation or neglect of adults who are at risk in Northern Ireland; to provide them with effective support and, where necessary, protective responses and access to justice for victims and their
families.The policy contributes to fulfilment of a Northern Ireland Executive Programme for Government commitment to deliver a package of measures to safeguard children and adults who may be at risk of harm and to promote a culture where safeguarding is everyone’s business.
The policy requires a cross- departmental approach within Government because the delivery of improved safeguarding outcomes is the business of us all, as individuals, as members of communities, as providers of services, and as Government Departments responsible for the delivery of strategies and policies which directly or indirectly impact on the lives of all adults including those at risk.
Zeroderma products are similar in formulation to around 50% of currently prescribed emollients. Offering cost savings of up to 37%, many Trusts have adopted the Zeroderma range onto their formularies and cost savings are being made without compromising on patient care.
By changing from branded emollients to the cost effective Zeroderma emollient range, Northern Ireland Health Trusts could save almost £400,000 a year.
All Zeroderma products are sodium lauryl sulphate (SLS) free and are available on prescription.
To request samples for patient evaluation, email:
zeroderma@thorntonross.com www.trderma.co.uk Thornton & Ross, Linthwaite, Huddersfield HD7 5QH 01484 842217
If Not Us, Who? Scarring and Stretch Mark Advice
89% of Pharmacists believe should be managed in pharmacy
With the treatment of minor ailments in primary care costing £2 billion annually, a new survey of UK retail pharmacists reveals that common skin conditions could be managed within the pharmacy setting. The survey, carried out by skincare treatment oil Bio-Oil, reveals that 89% of the pharmacists believe that concerns about stretch marks should and could be managed within pharmacies and 78% shared the same view for scars.
44
pharmacyinfocus.co.uk
Almost half of those asked (46%) stated that they feel they are best placed out of all healthcare professionals (HCPs) to offer advice to individuals around scarring and stretch marks. Scarring and stretch marks are highly prevalent, however, the survey revealed that patients are not making the best use of pharmacist knowledge with only a quarter of pharmacists being regularly asked for advice about pregnancy stretch marks, and 30% about reducing the appearance of scars caused by cuts or wounds. The survey also revealed that 90% of
pharmacists want to improve their knowledge about scarring and stretchmarks, to help them recommend appropriate products to patients.
Clinical Pharmacist, Steve Riley comments: “Scarring and stretch marks is an area that many HCPs do not have specific expertise in, and patients can find they do not get consistent advice. Pharmacists are often the first HCP that customers and patients seek advice from for scarring and stretch marks, with guidance and
appropriate training, we can support patients by advising on how to care for skin and how to minimise the appearance of scars and stretch marks.”
Bio-Oil has developed a free online training resource which helps to bridge this gap. Taking around 15 minutes to complete, the training covers key topics to help pharmacists provide advice to patients and provides you with an e-certificate following completion.
The training is available at: www/
bio-oilprofessional.co.uk/training/
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64